超声引导下半月板周围注射:解剖学描述与可行性研究
本研究先在4具尸体标本上描述超声引导下内侧和外侧半月板周围注射技术并评估注射物分布,随后回顾性评估35例连续患者(内侧30/35、外侧5/35退变性半月板撕裂)的临床效果;8次离体注射中7次(87.5%)准确,临床操作全部(35/35)技术成功,疼痛评分中位数从术前7降至6周随访时1.5(P<.0001),无并发症。
要点
- 超声引导下半月板周围注射在离体标本中7/8次(87.5%)准确,无半月板内注射或区域结构损伤。
- 临床35/35例操作技术成功,无并发症,疼痛评分中位数术前7、术中5、6周随访1.5(P<.0001)。
- 1次内侧注射误入胫侧副韧带而非半月板周围区,提示内侧入路需注意针尖位置。
核心结论
- 超声引导下半月板周围注射可准确、安全地将注射物递送至半月板周围区域,6周随访时糖皮质激素注射可显著缓解半月板疼痛症状,但需长期随访研究进一步评估其在半月板病变非手术治疗中的作用。
研究设计与样本
- 先在4具尸体标本上行超声引导下内侧和外侧半月板周围注射中国墨水后解剖评估注射物分布及结构损伤,再回顾性评估35例连续患者(内侧30/35、外侧5/35退变性半月板撕裂)在局部麻醉下行超声引导下半月板周围皮质类固醇注射。
关键影像表现/征象
- 离体标本中8次注射有7次(87.5%)准确,1次内侧半月板周围注射误入胫侧副韧带而非半月板周围区域。
- 无解剖标本出现半月板内注射或区域结构损伤。
诊断标准与关键数值
- 离体注射准确率为7/8(87.5%),以解剖评估注射物分布为准。
- 疼痛采用0-10数字语言评定量表(VRS)评估,中位数术前7(范围3-9)、术中5(范围0-10)、6周随访1.5(范围0-9),P<.0001。
临床应用与阅片要点
- 作者认为超声引导下半月板周围注射可准确、安全地用于半月板周围区域,6周时可显著缓解半月板疼痛症状。
- 作者指出需长期随访研究进一步评估半月板周围注射在半月板病变非手术治疗中的作用。
局限性
- 原文指出需长期随访的进一步研究来评估半月板周围注射在半月板病变非手术治疗中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To anatomically describe the ultrasound (US)-guided perimeniscal injection technique, and evaluate its feasibility in the treatment of meniscal pain.
METHODS: This work was initially undertaken in four cadaveric specimens with US-guided medial and lateral perimeniscal injection of China ink, followed by cadaveric dissection to assess injectate distribution, and potential injury to intra-articular and peri-articular structures. Then, 35 consecutive patients who underwent US-guided perimeniscal corticosteroid injection under local anesthesia for the treatment of symptomatic medial (30/35) or lateral (5/35) degenerative meniscal tear were retrospectively evaluated. Clinical outcome was assessed using a 0-10 numerical verbal rating scale (VRS) to evaluate severity of pain before, during, and after procedure at 6 weeks follow-up.
RESULTS: Seven of eight (87.5%) ex vivo injections were accurate. A single inaccurate medial perimeniscal injection infiltrated the tibial collateral ligament instead of the perimeniscal area. No anatomical specimen exhibited intrameniscal injection or injury to regional structures. All procedures (35/35) performed clinically were technically successful. Median VRS scores were: 7 (range, 3-9) before procedure, 5 (range, 0-10) during procedure, and 1.5 (range, 0-9) after procedure at 6 weeks follow-up (P <.0001). No complication was observed.
CONCLUSIONS: US-guided perimeniscal injections can accurately and safely deliver injectates in the perimeniscal area. In addition, our data suggest that perimeniscal corticosteroid injection provides significant symptom relief at 6 weeks in patients with meniscal pain. Further studies with long-term follow-up will be required to evaluate the role of perimeniscal injections in the nonoperative management of meniscal pathology.
引用
- Coll C, Coudreuse JM, Guenoun D, et al. Ultrasound-Guided Perimeniscal Injections: Anatomical Description and Feasibility Study. J Ultrasound Med. 2021. PMID: 33788316. doi:10.1002/jum.15700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。